Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial

Overview of attention for article published in OncoTargets and therapy, July 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,482 followers.

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic #breastcancer: a randomized... https://t.co/YOdZvDWnjd

Reply Repost Favourite

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a… https://t.co/DOv1NpIinr #breastcancer

Reply Repost Favourite